• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.冠状病毒病(COVID-19)的现状和未来展望:叙事性综述。
Int J Environ Res Public Health. 2020 Apr 14;17(8):2690. doi: 10.3390/ijerph17082690.
2
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.COVID-19 的病毒学、流行病学、发病机制和防控。
Viruses. 2020 Mar 27;12(4):372. doi: 10.3390/v12040372.
3
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
4
The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.新型冠状病毒全球紧急情况(SARS-CoV-2):现状更新与预测。
Int J Environ Res Public Health. 2020 Aug 5;17(16):5648. doi: 10.3390/ijerph17165648.
5
From SARS to COVID-19: What lessons have we learned?从 SARS 到 COVID-19:我们从中吸取了哪些教训?
J Infect Public Health. 2020 Nov;13(11):1611-1618. doi: 10.1016/j.jiph.2020.08.001. Epub 2020 Aug 21.
6
Coronavirus disease 2019 (COVID-19): A literature review.新型冠状病毒病 2019(COVID-19):文献综述。
J Infect Public Health. 2020 May;13(5):667-673. doi: 10.1016/j.jiph.2020.03.019. Epub 2020 Apr 8.
7
[Characteristics of SARS-CoV-2 and potential pharmacological treatment].[严重急性呼吸综合征冠状病毒2的特征及潜在药物治疗]
Postepy Biochem. 2020 May 9;66(2):83-90. doi: 10.18388/pb.2020_321.
8
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和新型冠状病毒(COVID-19)疫情,最新和最大的全球健康威胁:我们从中吸取了哪些教训?
Int J Epidemiol. 2020 Jun 1;49(3):717-726. doi: 10.1093/ije/dyaa033.
9
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
10
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).世界卫生组织宣布全球紧急状态:对 2019 年新型冠状病毒(COVID-19)的回顾。
Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26.

引用本文的文献

1
Long COVID-19: A Concept Analysis.长新冠:一项概念分析。
Infect Dis Rep. 2025 Jul 29;17(4):90. doi: 10.3390/idr17040090.
2
Spatio-temporal distribution of COVID-19 cases and tuberculosis in four provinces of Sumatra Islands, Indonesia.印度尼西亚苏门答腊岛四个省份新冠病例和结核病的时空分布
BMC Public Health. 2025 Feb 10;25(1):529. doi: 10.1186/s12889-025-21754-z.
3
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus.草药作为管理2型糖尿病合并新冠患者并发症的辅助疗法
Diabetes Metab Syndr Obes. 2025 Jan 16;18:135-146. doi: 10.2147/DMSO.S498774. eCollection 2025.
4
Protein Interaction Analysis and Molecular Simulation of the Anti-Inflammatory Activities in Extract Against COVID-19.提取物抗 COVID-19 抗炎活性的蛋白质相互作用分析与分子模拟
Int J Inflam. 2024 Nov 28;2024:5568294. doi: 10.1155/ijin/5568294. eCollection 2024.
5
Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients.用于即时检测新冠肺炎患者细胞因子的微流控免疫阵列
ACS Omega. 2024 Jun 24;9(27):29320-29330. doi: 10.1021/acsomega.4c00735. eCollection 2024 Jul 9.
6
Genomic epidemiology of severe acute respiratory syndrome coronavirus 2 from Theni, Tamil Nadu.来自泰米尔纳德邦特尼的严重急性呼吸综合征冠状病毒2的基因组流行病学。
J Family Med Prim Care. 2024 May;13(5):1727-1733. doi: 10.4103/jfmpc.jfmpc_1698_23. Epub 2024 May 24.
7
Exploring the Heart Failure Connection in Long COVID Patients: A Narrative Review.探索长新冠患者中的心力衰竭关联:一项叙述性综述
Cureus. 2024 Apr 21;16(4):e58694. doi: 10.7759/cureus.58694. eCollection 2024 Apr.
8
Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)信使核糖核酸(mRNA)疫苗及其血清免疫球蛋白G(IgG)水平会影响生育治疗和产科结局吗?一项观察性队列研究。
Clin Exp Med. 2024 Apr 23;24(1):81. doi: 10.1007/s10238-024-01345-9.
9
Fear of COVID-19 as a buffer in the relationship between perceived stress and life satisfaction in the Polish population at the beginning of the global pandemic.在全球大流行初期,对新冠病毒的恐惧作为波兰人群感知压力与生活满意度之间关系的缓冲因素。
Health Psychol Rep. 2020 Dec 26;9(2):149-159. doi: 10.5114/hpr.2020.102136. eCollection 2021.
10
Dysmenorrhea and heavy bleeding as complications in COVID-19-positive women: An observational study.新冠病毒检测呈阳性女性出现痛经和大量出血并发症的观察性研究。
J Family Med Prim Care. 2023 Sep;12(9):1849-1853. doi: 10.4103/jfmpc.jfmpc_1988_22. Epub 2023 Sep 30.

本文引用的文献

1
Stability of SARS-CoV-2 in different environmental conditions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在不同环境条件下的稳定性
Lancet Microbe. 2020 May;1(1):e10. doi: 10.1016/S2666-5247(20)30003-3. Epub 2020 Apr 2.
2
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws.托珠单抗治疗新冠病毒病患者的新治疗机遇:白细胞介素-6受体抑制剂与颌骨坏死的可能关联
Oral Oncol. 2020 Jul;106:104659. doi: 10.1016/j.oraloncology.2020.104659. Epub 2020 Mar 21.
3
Drug targets for corona virus: A systematic review.冠状病毒的药物靶点:系统评价。
Indian J Pharmacol. 2020 Jan-Feb;52(1):56-65. doi: 10.4103/ijp.IJP_115_20. Epub 2020 Mar 11.
4
The Novel Coronavirus (SARS-CoV-2) Epidemic.新型冠状病毒(严重急性呼吸综合征冠状病毒2)疫情
Ann Acad Med Singap. 2020 Mar 16;49(3):105-107.
5
Laboratory diagnosis of emerging human coronavirus infections - the state of the art.新型人冠状病毒感染的实验室诊断——现状。
Emerg Microbes Infect. 2020 Dec;9(1):747-756. doi: 10.1080/22221751.2020.1745095.
6
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.关于 SARS-CoV-2 感染潜在发病机制的假说——病毒性肺炎患者免疫变化的综述。
Emerg Microbes Infect. 2020 Dec;9(1):727-732. doi: 10.1080/22221751.2020.1746199.
7
COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China.新型冠状病毒肺炎感染疫情:中国黑龙江省的医疗管理策略
Crit Care. 2020 Mar 18;24(1):107. doi: 10.1186/s13054-020-2832-8.
8
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
9
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.新型冠状病毒病(COVID-19)在早期暴发期间的流行病学、病因、临床表现和诊断、预防和控制:范围综述。
Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x.
10
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?对 SARS-CoV-2 感染者的检测:基于实验室的检疫是否应该取代传统检疫?
Travel Med Infect Dis. 2020 Mar-Apr;34:101624. doi: 10.1016/j.tmaid.2020.101624. Epub 2020 Mar 14.

冠状病毒病(COVID-19)的现状和未来展望:叙事性综述。

Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.

机构信息

IRCCS Istituto Neurologico Mediterraneo NEUROMED, 86077 Pozzilli, Italy.

Italian Agency for Development Cooperation, Khartoum 79371, Sudan.

出版信息

Int J Environ Res Public Health. 2020 Apr 14;17(8):2690. doi: 10.3390/ijerph17082690.

DOI:10.3390/ijerph17082690
PMID:32295188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7215977/
Abstract

At the end of 2019 a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing severe acute respiratory syndrome expanded globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus a global pandemic. We performed a narrative review to describe existing literature with regard to Corona Virus Disease 2019 (COVID-19) epidemiology, pathophysiology, diagnosis, management and future perspective. MEDLINE, EMBASE and Scopus databases were searched for relevant articles. Although only when the pandemic ends it will be possible to assess the full health, social and economic impact of this global disaster, this review represents a picture of the current state of the art. In particular, we focus on public health impact, pathophysiology and clinical manifestations, diagnosis, case management, emergency response and preparedness.

摘要

2019 年底,一种新型病毒,严重急性呼吸系统综合症冠状病毒 2 型(SARS-CoV-2),由中国武汉引发,在全球范围内引发了严重急性呼吸系统综合症。2020 年 3 月,世界卫生组织宣布 SARS-CoV-2 病毒在全球范围内构成大流行。我们进行了叙述性综述,以描述有关新型冠状病毒病 2019(COVID-19)流行病学、病理生理学、诊断、管理和未来展望的现有文献。我们在 MEDLINE、EMBASE 和 Scopus 数据库中搜索了相关文章。尽管只有当大流行结束时,才能评估这一全球灾难对健康、社会和经济的全面影响,但这篇综述代表了目前的最新情况。特别是,我们关注公共卫生影响、病理生理学和临床表现、诊断、病例管理、应急响应和准备。